Acanthosis nigricans: A dermatologic marker of metabolic disease

Indian Journal of Dermatology, Venereology and Leprology

Volumn 68, Issue 2, 2002, Pages 67-72

  Varthakavi, P ^a   Waingankar, A ^a   Patel, K ^a   Wadhwa, S ^a   Khopkar, U ^a   Sengupta, R ^a   Merchant, P ^a   Mehtalia, S ^a   Nihalani, K ^a  

^a BYL NAIR CHARITABLE HOSPITAL   (India)

Author keywords

Acanthosis nigricans; Diabetes; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN; MARKER;

ACANTHOSIS NIGRICANS; ADULT; AGE DISTRIBUTION; ARTICLE; BODY FAT; BODY FAT DISTRIBUTION; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOATROPHY; MALE; METABOLIC DISORDER; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PATIENT REFERRAL; SKIN BIOPSY; STATISTICAL SIGNIFICANCE;

EID: 33745963533     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Curth HO. Classification of acanthosis nigricons. Int J Dermatol 1976;15:592.
2. Kahn RC, Flier JS, Bar RS. The syndromes of insulin resistance and acanthosis nigricans. Insulin receptor disorders in man. N Eng J Med 1976;294:739-745.
3. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
4. Denke M, Wison JD. Assessment of nutritional status. In: Harrison's Principle of Internal Medicine (Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, eds) 14th edn. New York: Mc Grow - Hill 1998;448-454.
5. Skin signs of systemic disease In: Clinical Dematology (Demis DJ, ed), Vol.4, Philadelphia 1986;12-26.
6. Akinmokun A, Selby PL, Romaiya K, et al. The short insulin tolerance test for determination of insulin sensitivity: A comparison with the euglycemic clamp. Diabetes Med 1992;9:432-437.
7. World Health Organization. WHO Study Group on Diabetes Mellitus. Technical Report Series. 727, Geneva, WHO, 1985.
8. Reaven G, Miller R. Study of the relationship between glucose and insulin responses to an oral glucose load in man. Diabetes 1968;17:560-569.
9. Van Itallie TB, Lew EA. Assessment of morbidity and mortality risk in the overweight patient. In: Treatment of Seriously Obese Patient wadden TA, Van itallie TB, eds, New York: The Guilford Press, 1992;332.
10. Bray GA. The syndromes of obesity: An endocrine approach. In: Endocrinology, Degroot U, Besser M, Burger HG, eds, Philadelphia: WB. Saunders & Co., 1995; 2624-2662.
11. Stuart CA, Gilkison CR, Keenan DS, et al. Hyperinsulinemia and acanthosis nigricans in Africans. J National Med Asso 1997;89:523-527.
12. Stuart CA, Smith MM, Gilkison CR, et al. Acanthosis nigricans among native Americans - an indicator of high diabetes risk. Am J Public Health 1994;84:1839-1842.
13. Stuart CA, Pate CJ, Peters EJ. Prevalence of acanthosis nigricans in an unselected population. Am J Med 1984;87:269-272.
14. Endocrine Diseases In: Diseases of the Skin. Clinical Endocrinology (Arnold HL, Odom RB, James WD, eds), Philadelphia, WB Saunders Co 1990;579-584.
15. Grasinger CC, Wild RA, Parker LJ. Vulvar acanthosis nigricans. A marker of insulin resistance in hirsute women. Fertil Steril 1993;579-584.
16. McLean DL, Hynes HA. Cutaneous aspects of internal malignant disease. In: Dermatology in General Medicine, Fitzpatrick TB, Eisen AZ, Wolff, Freedberg IM, Frank AK, eds New York, Mcgraw Hill Book Co., 1987;1917-1937.
17. Dunaif A, Green G, Phelps RG, et al. Acanthosis nigricans, Insulin action and hyperandrogenism: Clinical, histological and biochemical findings. J Clin Endo Metab 1991;73:590-595.
18. Prentice AM, Black AE, Coward WA. High levels of energy expenditure in obese women. Br Med J 1986;292:983-987.
19. Olefsky JM. Diabetes mellitus (Type II) - Etiology and pathogenesis. In: Endocrinology DeGroot L, Besser M, Burger HG, eds, Philadelphia, WB. Saunders and Co. 1995;1436-1463.
20. Rogers DL. Acanthosis nigricans. Seminar Dermatol 1991;10:160-161.